{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:33Z","timestamp":1790835153337,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0012"],"award-info":[{"award-number":["P1-0012"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0043"],"award-info":[{"award-number":["P3-0043"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12640-019-00149-0","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:55:28Z","timestamp":1576068928000},"page":"724-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study"],"prefix":"10.1007","volume":"37","author":[{"given":"Domen","family":"Pregeljc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Teodorescu-Perijoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejc","family":"Umek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-6367","authenticated-orcid":false,"given":"Janez","family":"Mavri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"149_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","volume":"73","author":"AI Bernstein","year":"2014","unstructured":"Bernstein AI, Stout KA, Miller GW (2014) The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int 73:89\u201397. https:\/\/doi.org\/10.1016\/j.neuint.2013.12.003","journal-title":"Neurochem Int"},{"key":"149_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-4682-6-21","volume":"6","author":"JA Best","year":"2009","unstructured":"Best JA, Nijhout HF, Reed MC (2009) Homeostatic mechanisms in dopamine synthesis and release: a mathematical model. Theor Biol Med Model 6:21. https:\/\/doi.org\/10.1186\/1742-4682-6-21","journal-title":"Theor Biol Med Model"},{"key":"149_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194\u2013202. https:\/\/doi.org\/10.1016\/j.tins.2007.03.006","journal-title":"Trends Neurosci"},{"key":"149_CR4","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1002\/ejoc.201100873","volume":"2011","author":"R Bor\u0161tnar","year":"2011","unstructured":"Bor\u0161tnar R, Repi\u010d M, Kr\u017ean M, Mavri J, Vianello R (2011) Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: a computational study. Eur J Org Chem 2011:6419\u20136433. https:\/\/doi.org\/10.1002\/ejoc.201100873","journal-title":"Eur J Org Chem"},{"key":"149_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"149_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acschemneuro.6b00304","volume":"8","author":"ZD Brodnik","year":"2017","unstructured":"Brodnik ZD, Ferris MJ, Jones SR, Espa\u00f1a RA (2017) Reinforcing doses of intravenous cocaine produce only modest dopamine uptake inhibition. ACS Chem Neurosci 8:281\u2013289. https:\/\/doi.org\/10.1021\/acschemneuro.6b00304","journal-title":"ACS Chem Neurosci"},{"key":"149_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"L Chen","year":"2008","unstructured":"Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28:425\u2013433. https:\/\/doi.org\/10.1523\/JNEUROSCI.3602-07.2008","journal-title":"J Neurosci"},{"key":"149_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM (2017) Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem 86:27\u201368. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-045115","journal-title":"Annu Rev Biochem"},{"key":"149_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/clpt.1985.179","volume":"38","author":"MJ Chow","year":"1985","unstructured":"Chow MJ, Ambre JJ, Ih Ruo T, Atkinson AJ, Bowsher DJ, Fischman MW (1985) Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther 38:318\u2013324. https:\/\/doi.org\/10.1038\/clpt.1985.179","journal-title":"Clin Pharmacol Ther"},{"key":"149_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mds.22915","volume":"25","author":"CW Christine","year":"2010","unstructured":"Christine CW, Garwood ER, Schrock LE, Austin DE, McCulloch CE (2010) Parkinsonism in patients with a history of amphetamine exposure. Mov Disord 25:228\u2013231. https:\/\/doi.org\/10.1002\/mds.22915","journal-title":"Mov Disord"},{"key":"149_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060763","volume":"8","author":"DP Covey","year":"2013","unstructured":"Covey DP, Juliano SA, Garris PA (2013) Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine. PLoS One 8:e60763. https:\/\/doi.org\/10.1371\/journal.pone.0060763","journal-title":"PLoS One"},{"key":"149_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","volume":"146","author":"K Curtin","year":"2015","unstructured":"Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015) Methamphetamine\/amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment. Drug Alcohol Depend 146:30\u201338. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.027","journal-title":"Drug Alcohol Depend"},{"key":"149_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00003088-200443030-00002","volume":"43","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet 43:157\u2013185. https:\/\/doi.org\/10.2165\/00003088-200443030-00002","journal-title":"Clin Pharmacokinet"},{"key":"149_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1871527316666170124165222","volume":"16","author":"L Dezsi","year":"2017","unstructured":"Dezsi L, Vecsei L (2017) Monoamine oxidase B inhibitors in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 16:425\u2013439. https:\/\/doi.org\/10.2174\/1871527316666170124165222","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"149_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/07391102.2018.1426044","volume":"37","author":"Teodora Djikic","year":"2018","unstructured":"Djikic T, Mart\u00ed Y, Spyrakis F, Lau T, Benedetti P, Davey G, Schloss P, Yelekci K (2018) Human dopamine transporter: the first implementation of a combined in silico\/in vitro approach revealing the substrate and inhibitor specificities. J Biomol Struct Dyn:1\u201316. https:\/\/doi.org\/10.1080\/07391102.2018.1426044","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"149_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/tx600325u","volume":"20","author":"P Fuentes","year":"2007","unstructured":"Fuentes P, Paris I, Nassif M, Caviedes P, Segura-Aguilar J (2007) Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line-an experimental cell model for dopamine toxicity studies. Chem Res Toxicol 20:776\u2013783. https:\/\/doi.org\/10.1021\/tx600325u","journal-title":"Chem Res Toxicol"},{"key":"149_CR17","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1523\/jneurosci.18-13-04861.1998","volume":"18","author":"F Fumagalli","year":"1998","unstructured":"Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 18:4861\u20134869. https:\/\/doi.org\/10.1523\/jneurosci.18-13-04861.1998","journal-title":"J Neurosci"},{"key":"149_CR18","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1523\/jneurosci.19-07-02424.1999","volume":"19","author":"F Fumagalli","year":"1999","unstructured":"Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19:2424\u20132431. https:\/\/doi.org\/10.1523\/jneurosci.19-07-02424.1999","journal-title":"J Neurosci"},{"key":"149_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","volume":"8","author":"A Herrera","year":"2017","unstructured":"Herrera A, Mu\u00f1oz P, Steinbusch HWM, Segura-Aguilar J (2017) Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease? ACS Chem Neurosci 8:702\u2013711. https:\/\/doi.org\/10.1021\/acschemneuro.7b00034","journal-title":"ACS Chem Neurosci"},{"key":"149_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.npep.2008.05.006","volume":"42","author":"J Jia","year":"2008","unstructured":"Jia J, Chen X, Zhu W, Luo Y, Hua Z, Xu Y (2008) CART protects brain from damage through ERK activation in ischemic stroke. Neuropeptides 42:653\u2013661. https:\/\/doi.org\/10.1016\/j.npep.2008.05.006","journal-title":"Neuropeptides"},{"key":"149_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2133\/dmpk.17.199","volume":"17","author":"T Kamada","year":"2002","unstructured":"Kamada T, Chow T, Hiroi T, Imaoka S, Morimoto K, Ohde H, Funae Y (2002) Metabolism of selegiline hydrochloride, a selective monoamine b-type inhibitor, in human liver microsomes. Drug Metab Pharmacokinet 17:199\u2013206","journal-title":"Drug Metab Pharmacokinet"},{"key":"149_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/B978-0-12-374585-9.00009-8","volume-title":"A Pharmacology Primer","author":"Terry P. Kenakin","year":"2009","unstructured":"Kenakin T (2009) Pharmacokinetics. In: Kenakin T, A pharmacology primer, 3rd edn. Academic Press, London, pp 179-214"},{"key":"149_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2011.1205","volume":"306","author":"BM Kuehn","year":"2011","unstructured":"Kuehn BM (2011) Meth use linked to risk of Parkinson disease. JAMA 306:814. https:\/\/doi.org\/10.1001\/jama.2011.1205","journal-title":"JAMA"},{"key":"149_CR24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1046\/j.1471-4159.1999.01982.x","volume":"73","author":"SR Letchworth","year":"1999","unstructured":"Letchworth SR, Sexton T, Childers SR, Vrana KE, Vaughan RA, Davies HM, Porrino LJ (1999) Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. J Neurochem 73:1982\u20131989","journal-title":"J Neurochem"},{"key":"149_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","volume":"70","author":"Y Liu","year":"1992","unstructured":"Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539\u2013551. https:\/\/doi.org\/10.1016\/0092-8674(92)90425-C","journal-title":"Cell"},{"key":"149_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","volume":"172","author":"C Liu","year":"2018","unstructured":"Liu C, Kershberg L, Wang J, Schneeberger S, Kaeser PS (2018) Dopamine secretion is mediated by sparse active zone-like release sites. Cell 172:706\u2013718.e15. https:\/\/doi.org\/10.1016\/j.cell.2018.01.008","journal-title":"Cell"},{"key":"149_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuroscience.2005.09.035","volume":"137","author":"SA Lloyd","year":"2006","unstructured":"Lloyd SA, Faherty CJ, Smeyne RJ (2006) Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 137:905\u2013913. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.09.035","journal-title":"Neuroscience"},{"key":"149_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1021\/acschemneuro.5b00010","volume":"6","author":"KM Lohr","year":"2015","unstructured":"Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW (2015) Increased vesicular monoamine transporter 2 (VMAT2; Slc18a2) protects against methamphetamine toxicity. ACS Chem Neurosci 6:790\u2013799. https:\/\/doi.org\/10.1021\/acschemneuro.5b00010","journal-title":"ACS Chem Neurosci"},{"key":"149_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","volume":"6","author":"A Martorana","year":"2014","unstructured":"Martorana A, Koch G (2014) Is dopamine involved in Alzheimer\u2019s disease? Front Aging Neurosci 6:252. https:\/\/doi.org\/10.3389\/fnagi.2014.00252","journal-title":"Front Aging Neurosci"},{"key":"149_CR30","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1021\/acs.jpcb.6b00894","volume":"120","author":"J Mavri","year":"2016","unstructured":"Mavri J, Matute RA, Chu ZT, Vianello R (2016) Path integral simulation of the H\/D kinetic isotope effect in monoamine oxidase B catalyzed decomposition of dopamine. J Phys Chem B 120:3488\u20133492. https:\/\/doi.org\/10.1021\/acs.jpcb.6b00894","journal-title":"J Phys Chem B"},{"key":"149_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.clpt.2006.06.013","volume":"80","author":"J Mendelson","year":"2006","unstructured":"Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT (2006) Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 80:403\u2013420. https:\/\/doi.org\/10.1016\/j.clpt.2006.06.013","journal-title":"Clin Pharmacol Ther"},{"key":"149_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.bbadis.2012.03.010","volume":"1822","author":"P Mu\u00f1oz","year":"2012","unstructured":"Mu\u00f1oz P, Paris I, Sanders LH, Greenamyre JT, Segura-Aguilar J (2012) Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochim Biophys Acta 1822:1125\u20131136. https:\/\/doi.org\/10.1016\/j.bbadis.2012.03.010","journal-title":"Biochim Biophys Acta"},{"key":"149_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12640-009-9148-4","volume":"18","author":"I Paris","year":"2010","unstructured":"Paris I, Perez-Pastene C, Cardenas S, Iturriaga-Vasquez P, Iturra P, Mu\u00f1oz P, Couve E, Caviedes P, Segura-Aguilar J (2010) Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox Res 18:82\u201392. https:\/\/doi.org\/10.1007\/s12640-009-9148-4","journal-title":"Neurotox Res"},{"key":"149_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00702-013-1016-y","volume":"120","author":"M Pavlin","year":"2013","unstructured":"Pavlin M, Mavri J, Repi\u010d M, Vianello R (2013) Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor. J Neural Transm 120:875\u2013882. https:\/\/doi.org\/10.1007\/s00702-013-1016-y","journal-title":"J Neural Transm"},{"key":"149_CR35","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s12035-015-9284-1","volume":"53","author":"M Pavlin","year":"2016","unstructured":"Pavlin M, Repi\u010d M, Vianello R, Mavri J (2016) The chemistry of neurodegeneration: kinetic data and their implications. Mol Neurobiol 53:3400\u20133415. https:\/\/doi.org\/10.1007\/s12035-015-9284-1","journal-title":"Mol Neurobiol"},{"key":"149_CR36","doi-asserted-by":"publisher","first-page":"11419","DOI":"10.1021\/acs.jpcb.6b09011","volume":"120","author":"M Pober\u017enik","year":"2016","unstructured":"Pober\u017enik M, Purg M, Repi\u010d M, Mavri J, Vianello R (2016) Empirical valence bond simulations of the hydride-transfer step in the monoamine oxidase a catalyzed metabolism of noradrenaline. J Phys Chem B 120:11419\u201311427. https:\/\/doi.org\/10.1021\/acs.jpcb.6b09011","journal-title":"J Phys Chem B"},{"key":"149_CR37","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.2174\/092986712803988811","volume":"19","author":"C Pomara","year":"2012","unstructured":"Pomara C, Cassano T, D\u2019Errico S, Bello S, Romano AD, Riezzo I, Serviddio G (2012) Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. Curr Med Chem 19:5647\u20135657. https:\/\/doi.org\/10.2174\/092986712803988811","journal-title":"Curr Med Chem"},{"key":"149_CR38","doi-asserted-by":"publisher","first-page":"e2444","DOI":"10.1371\/journal.pone.0002444","volume":"3","author":"Z Qi","year":"2008","unstructured":"Qi Z, Miller GW, Voit EO (2008) Computational systems analysis of dopamine metabolism. PLoS One 3:e2444. https:\/\/doi.org\/10.1371\/journal.pone.0002444","journal-title":"PLoS One"},{"key":"149_CR39","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1021\/jp500795p","volume":"118","author":"M Repi\u010d","year":"2014","unstructured":"Repi\u010d M, Purg M, Vianello R, Mavri J (2014) Examining electrostatic preorganization in monoamine oxidases A and B by structural comparison and pKa calculations. J Phys Chem B 118:4326\u20134332. https:\/\/doi.org\/10.1021\/jp500795p","journal-title":"J Phys Chem B"},{"issue":"24","key":"149_CR40","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1021\/acs.jpcb.8b02304","volume":"122","author":"Mikko Salom\u00e4ki","year":"2018","unstructured":"Salom\u00e4ki MO, Marttila L, Kivel\u00e4 H, Ouvinen T, Lukkari JO (2018) Effect of pH and oxidant on the first steps of polydopamine formation: a thermodynamic approach. J Phys Chem B acs.jpcb.8b02304. https:\/\/doi.org\/10.1021\/acs.jpcb.8b02304","journal-title":"The Journal of Physical Chemistry B"},{"key":"149_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.neuro.28.061604.135722","volume":"30","author":"W Schultz","year":"2007","unstructured":"Schultz W (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30:259\u2013288. https:\/\/doi.org\/10.1146\/annurev.neuro.28.061604.135722","journal-title":"Annu Rev Neurosci"},{"key":"149_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnins.2018.00106","volume":"12","author":"J Segura-Aguilar","year":"2018","unstructured":"Segura-Aguilar J, Huenchuguala S (2018) Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson\u2019s disease. Front Neurosci 12:106. https:\/\/doi.org\/10.3389\/fnins.2018.00106","journal-title":"Front Neurosci"},{"key":"149_CR43","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jnc.12686","volume":"129","author":"J Segura-Aguilar","year":"2014","unstructured":"Segura-Aguilar J, Paris I, Mu\u00f1oz P, Ferrari E, Zecca L, Zucca FA (2014) Protective and toxic roles of dopamine in Parkinson\u2019s disease. J Neurochem 129:898\u2013915. https:\/\/doi.org\/10.1111\/jnc.12686","journal-title":"J Neurochem"},{"key":"149_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","volume":"33","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639\u2013676. https:\/\/doi.org\/10.1146\/annurev.pa.33.040193.003231","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"149_CR45","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1523\/JNEUROSCI.4050-13.2014","volume":"34","author":"CA Siciliano","year":"2014","unstructured":"Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2014) Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci 34:5575\u20135582. https:\/\/doi.org\/10.1523\/JNEUROSCI.4050-13.2014","journal-title":"J Neurosci"},{"key":"149_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/FNMOL.2018.00467","volume":"11","author":"N Umek","year":"2018","unstructured":"Umek N, Gersak B, Vintar N, Sostaric M, Mavri J (2018) Dopamine autoxidation is controlled by acidic pH. Front Mol Neurosci 11:467. https:\/\/doi.org\/10.3389\/FNMOL.2018.00467","journal-title":"Front Mol Neurosci"},{"key":"149_CR47","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1002\/ejoc.201201122","volume":"2012","author":"R Vianello","year":"2012","unstructured":"Vianello R, Repi\u010d M, Mavri J (2012) How are biogenic amines metabolized by monoamine oxidases? Eur J Org Chem 2012:7057\u20137065. https:\/\/doi.org\/10.1002\/ejoc.201201122","journal-title":"Eur J Org Chem"},{"key":"149_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/cn400019q","volume":"4","author":"TL Vickrey","year":"2013","unstructured":"Vickrey TL, Xiao N, Venton BJ (2013) Kinetics of the dopamine transporter in Drosophila larva. ACS Chem Neurosci 4:832\u2013837. https:\/\/doi.org\/10.1021\/cn400019q","journal-title":"ACS Chem Neurosci"},{"key":"149_CR49","first-page":"RA17","volume":"11","author":"Y Watanabe","year":"2005","unstructured":"Watanabe Y, Himeda T, Araki T (2005) Mechanisms of MPTP toxicity and their implications for therapy of Parkinson\u2019s disease. Med Sci Monit 11:RA17\u2013RA23","journal-title":"Med Sci Monit"},{"key":"149_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainresbull.2008.12.014","volume":"79","author":"E Yablonsky-Alter","year":"2009","unstructured":"Yablonsky-Alter E, Agovic MS, Gashi E, Lidsky TI, Friedman E, Banerjee SP (2009) Cocaine challenge enhances release of neuroprotective amino acid taurine in the striatum of chronic cocaine treated rats: a microdialysis study. Brain Res Bull 79:215\u2013218. https:\/\/doi.org\/10.1016\/j.brainresbull.2008.12.014","journal-title":"Brain Res Bull"},{"key":"149_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/adb.12271","volume":"22","author":"J Yuan","year":"2017","unstructured":"Yuan J, Liu XD, Han M, Lv RB, Wang YK, Zhang GM, Li Y (2017) Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects. Addict Biol 22:229\u2013234. https:\/\/doi.org\/10.1111\/adb.12271","journal-title":"Addict Biol"},{"issue":"2","key":"149_CR52","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","volume":"10","author":"Shun Zhang","year":"2018","unstructured":"Zhang S, Wang R, Wang G (2018) Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem Neurosci acschemneuro.8b00454. https:\/\/doi.org\/10.1021\/acschemneuro.8b00454","journal-title":"ACS Chemical Neuroscience"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00149-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T12:18:22Z","timestamp":1722169102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00149-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00149-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}